MANHEIM, GERMANY, April 28, 2019 – Myocardial Solutions’ MyoStrain® was featured in four different abstracts presented at the 85th Annual Conference of the German Society of Cardiology (DGK). The event was held in Mannheim, Germany on April 24th-27th, 2019. The abstracts addressed the multiple uses for MyoStrain across indications covering the following topics:
- A comparison of MyoStrain to left ventricular ejection fraction in their ability to detect subclinical cardiac dysfunction across various cardiac diseases
- Using MyoStrain as a triage tool for patients with acute chest pain in the emergency room
- The interim results of a study that used MyoStrain to detect cardiotoxicity from carfilzomib, an anti-cancer drug, in multiple myeloma patients
- The opportunity to use MyoStrain for cardiac involvement in patients with Wilson’s disease
Links to the abstracts are provided below:
Citation: Montenbruck M, et al. Fast-SENC intramyocardial strain detects cardiac dysfunction before ejection fraction. DGK 2019. (n=674)
Citation: Siry D, et al. Interim study: analysis of myocardial deformation using fSENC-CMR on patients with chest pain. DGK 2019. (n=20)
Citation: Nooman NA, et al. Cardiac MRI for relapsed multiple myeloma patients: detection and prediction of cardiotoxicity related to Carfilzomib therapy. DGK 2019. (n=8)
Citation: Salatzki J, et al. Cardiac tissue characterization in patients with Wilson’s disease using cardiac magnetic resonance imaging. DGK 2019. (n=32)
About Myocardial Solutions, Inc.
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, non-invasive heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.